Anorexia nervosa: an update on genetic, biological and clinical aspects in males

Emilia Manzato1, Malvina Gualandi2, Cristina Tarabbia3, Deborah Romano4, Lorenza Di Pascoli5, Giovanni Scanelli6

1. Psychiatrist, Chief of the Eating Disorders Unit, “Salus” Private Hospital, Ferrara, Italy;

2. Medical Doctor, Internal Medicine, Member of AIDM and SISDCA, Ferrara, Italy;

3. Medical Doctor, Department of Life Sciences and Biotechnologies, University of Ferrara, Italy;

4. Medical Doctor, AIDM President, Ferrara, Italy;

5. Internal Medicine Unit, S. Bortolo Hospital, Aulss 8 Vicenza, Italy;

6. Chief of the Internal Medicine Unit, S. Bortolo Hospital, Aulss 8 Vicenza, Italy.

Received 13 June 2017; accepted 24 July 2017.

Summary. Although in the last decades the presence of anorexia nervosa (AN) in males has been reported in many papers, it is still considered a female disease. This paper aims to evaluate the diagnostic process in males. We attempt to determine whether the diagnosis could be underestimated for cultural reasons – the disease is not accepted by males or recognized by professional caregivers – or for the lack of neutrality of diagnostic tools, which are calibrated on females. The transition from Diagnostic and Statistical Manual of Mental Disorders, 4th ed. to the new diagnostic system (5th ed.), introducing more inclusive and sex-neutral diagnostic criteria has implemented, particularly in males, the full diagnosis of AN often classified as Eating Disorders Not Otherwise Specified. The main epidemiologic data have been reviewed as well as gender-bound biologic factors influencing the development of AN in the two genders and marking a difference in its phenotypic expression: genetic, biological, behavioral, and environmental factors. Finally, the clinical aspects of anorexic disorder in males have been examined in search for a possible specificity in the male gender. Male adolescents have slower and later pubertal development than females, therefore the occurrence of malnutrition exposes them to irreversible risks (short stature), or poorly reversible risks (failure to reach adequate peak bone mass). In addition, early diagnosis and treatment, both positively associated to a better prognosis, appear more difficult in males often presenting a greater focus on muscularity.

Key words: male anorexia nervosa, epidemiology, risk factors, gender differences, clinical features, medical complications.

Anoressia nervosa: aggiornamento sugli aspetti genetici, biologici e clinici nel sesso maschile

Riassunto. Nonostante nelle ultime decadi molti articoli abbiano evidenziato casi di anoressia maschile, l’anoressia nervosa (AN) è storicamente considerata una malattia prevalentemente femminile. Questo articolo si interroga sul processo diagnostico nel maschio. In particolare si chiede se la diagnosi venga sottostimata per ragioni culturali – stigma di malattia femminile non accettata dal paziente né riconosciuta dai “caregiver” – o piuttosto per l’uso di strumenti diagnostici tarati sino a oggi sul sesso femminile. Il passaggio dal Diagnostic and Statistical Manual of mental disorder, 4th ed. al DSM-5 ha introdotto una maggiore inclusività e neutralità nei criteri diagnostici, implementando la diagnosi di AN nei casi, soprattutto maschili, che venivano generalmente definiti come sindromi non altrimenti specificate. Inoltre verranno riassunti i principali dati epidemiologici ed esaminate le differenze di genere che influenzano lo sviluppo della patologia e ne marcano una differenza nella espressione fenotipica: fattori genetici, biologici, comportamentali, ambientali. Infine vengono trattati gli aspetti clinici della AN nel maschio. L’adolescente maschio, a più lento e tardivo sviluppo puberale, è più esposto a rischi irreversibili (bassa statura), o scarsamente reversibili (per es. mancato raggiungimento del picco di massa ossea). La diagnosi precoce e un trattamento tempestivo, entrambi positivamente associati a prognosi migliore, appaiono più difficoltosi nel maschio che può inoltre presentare una maggiore focalizzazione su aspetti di muscolarizzazione.

Parole chiave: anoressia nervosa maschile, epidemiologia, fattori di rischio, differenze di genere, aspetti clinici, complicazioni mediche.


Eating disorders (ED) are psychiatric disorders that deeply affect the physical health and social functioning of patients. The first description of a case in which starvation and undernutrition were related to a psychiatric illness was made in 1689 by Sir Richard Morton, an English physician, and concerned a male subject, the 16-year-old son of a church minister. Sir Morton defined this condition as “nervous consumption” subsequently renamed anorexia nervosa.

So far, anorexia nervosa (AN) has been mainly described in women but its real nature was not clear for a long time. In the first half of the last century it was considered as an endocrine disorder and confused with Simmond’s disease (a pituitary disorder with amenorrhea that has a clinical picture very similar to AN). Only in the second half of the 1990s, thanks to studies by Hilde Bruch, AN was finally recognized as a psychiatric illness characterized by a fundamental core symptom: body image distortion.

AN was classified, for the first time, among serious psychiatric disorders in the third edition of the “Diagnostic and Statistical Manual of Mental Disorders” (DSM) in the 1980s as an Eating Disorder, characterized by a central core feature, body image distortion, refusal of food, fear of gaining weight. Body image distortion means that a subject with a normal weight or even underweight sees him/herself as overweight and therefore he/she is not able to accept a normal weight, defined as a Body Mass Index (BMI) greater than or equal to 18.5 in females, to 19.5 in males.

The methods used to become and stay underweight may be a severe food restrictions associated with physical hyperactivity or purging behaviors such as self-induced vomiting and use of laxatives and/or diuretics.

DSM-4, edited by the American Psychiatric Association (APA), defined diagnostic criteria mostly tailored for the female gender, which were in use till 2013, when they were modified in the 5th edition as a result of a wide variety of criticisms1. The amenorrhea criterion (absence of at least three consecutive menstrual cycles) was removed since, in females, the absence of amenorrhea was not associated to a significantly different course of AN, and in addition males were excluded from this symptom2. Actually, neither a low level of testosterone nor a decrease in sexual drive had the same dramatic meaning as amenorrhea. In addition, BMI values were too low for men and were not evaluated in the context of the nutritional history. Therefore, most males with anorexia were included in the category of Eating Disorder Not Otherwise Specified (EDNOS).

A substantial revision of DSM-4 diagnostic criteria resulted in the more sex-neutral and more inclusive diagnostic criteria established in DSM-5. According to the new criteria, previously overweight patients, presenting an impressive weight decrease and core symptoms of anorexia could be included in the AN category even if BMI was within normal ranges. This condition was particularly observed in males who often reported a history of overweight before the onset of the anorectic behavior.

Another difficulty in diagnosing male AN is linked to the use, in epidemiological surveys, of the same diagnostic tools (i.e. Tests, Questionnaires etc.) tailored for females, not taking into account gender differences. For example, the ED Examination (EDE), a useful test for identifying AN subjects, particularly adolescents, is not fully adequate for males.

The first medical approach in all subjects, but particularly in males, is a crucial step: from the very beginning, the doctor who will be treating the subject should try to establish with him a relationship as deep and trustful as possible, since only within a trust-based relationship it becomes possible to ask questions regarding the psychic sphere, i.e. concerns about physical fitness, body misperception or depressive feelings.

Even when a correct diagnosis (or a suspected diagnosis) is formulated, the first obstacle that needs to be overcome is motivating the subject to undergo treatment: in fact, patients with anorexia are often brought to the first visit by their families, since egosyntony-and/or poor awareness contribute to deny the problem.

The high rate of medical complications and mortality and the complexity of clinical features of anorexia in males, as in females, require a skilled team consisting of internists, dieticians, and psychiatrists able to contribute to the early diagnosis of anorexia disease, and to organize the type and setting of treatment, depending on the severity of the general conditions and the subject’s compliance. This multidisciplinary model has been recognized as the best intervention model in ED and is recommended by APA’s 2006 evidence-based guidelines. According to APA’s practice guidelines on ED, the first-line treatment (“recommended with substantial clinical confidence”) is a model of care based on a team approach: “In treating adults with ED, the psychiatrist may assume the leadership role within a program or team that includes other physicians, psychologists, registered dieticians, and social workers”3.


EDs are considered female gender-bound disorders since males appear to be affected by the disease to a lesser extent than females. This view, persistent over time, has led to a significant underestimation of ED in males, who, consequently, have not been adequately studied -except in very limited or “mixed” samples- either with regard to the diagnostic process or to treatment4,5. In fact, ED in males, and in particular AN, appear to be a very challenging area starting from the reliability of epidemiological data.

A recent review by Raevuori A. reported a lifetime prevalence of ED in males ranging from 0.16% to 0.3% for AN, 0.1-0.5% for bulimia (BN) and 1.1-3.1% for binge eating disorder (BED) and a highly variable males/ females ratio, from 1:3 to 1:126. A Finnish study, by the same author, involving a large cohort of 2,122 twin males – 22-27-year-old – from the general population, reported that the lifetime prevalence of AN in males was 0.24% while the incidence in 10-24.9 year-old males was found to be 15.7 per 100,000 people per year7.

According to data reported by the Italian Ministry of Health, the incidence of AN is estimated to be at least 8 new cases per 100,000 persons per year among women, and 0.02-1.4 new cases per 100,000 persons per year among men; the lifetime prevalence in males was found to be 0.3%8.

The prevalence of ED appears to increase over time and, in particular, a statistically significant increase in AN prevalence has been reported in the general population9. A British study points out that there is a discrepancy between the data of clinical population, in which males account for about 5-10% of all patients with AN, and data of the general population, where males with AN appear to be 25%10.

It is definitely hard to get a true picture of the prevalence and incidence of AN in males, since data from the general population are very different and hardly comparable with data from clinical samples: this statement is true for all data concerning ED, but particularly for data regarding AN spread among the general male population. Moreover, as pointed out in a recent review on the epidemiology of eating disorders in males11, the diagnostic criteria of DSM-IV relegated most of male patients with AN in the EDNOS group: the lifetime prevalences of EDNOS in male adolescents and adults were 3.9 and 3.4%, respectively, much higher than in females6,12. In addition, early detection of AN in men is hampered by many factors: the lack of awareness both in the family and even in general practitioners (GPs) about the presence of AN in males is a crucial point. GPs, in fact, may be the first to be consulted by the patient or his family, but very often they are not sufficiently skilled at recognizing the presence of anorectic symptoms in a male. It is believed that only 50% of patients addressing their GPs for symptoms linked to an ED are correctly diagnosed13. The delay in diagnosis and consequently in treatment may lead to a worsening of the clinical picture, and over time to chronicity of the disorder. In a survey addressing males with ED14, patients reported how much the common stereotype – “ED is a female disease” – had contributed significantly to a delayed recognition of their symptoms and consequently to an adequate treatment. A British study, specifically investigating how ED in males were represented in the newspapers15, reported poor visibility of this problem in the press, even if the number of newspaper articles addressing this theme had increased by 4 times from 2002 to 2012, as well as the number of ED cases in men in the same period. Furthermore, in the newspaper articles the gender specificity of ED and the presence of female traits in male patients with AN were stressed.

In addition, the diagnostic delay may be due both to a strong “egosyntony” with the ED, typical of AN in both genders, and to the prevalent gender-female-orientation of diagnostic tools and treatment setting in ED Units.

Within this scope, ED Examination (EDE), despite showing its usefulness in identifying an ED especially in adolescents, provides an abnormal scoring in males especially in items testing the drive for thinness and body concerns16.

Gender-bound biological risk factors

The origin of gender dimorphism observed in AN is still partially unknown: classically related to socio-cultural conditions, the etiology of the disorder appears to be also related to biological mechanisms such as genetic, neuronal and hormonal.

Genetic factors

The interaction between the environment and multiple genes with a low single effect is somewhat controversial in AN, and papers analyzing the rate of inheritance of this disorder in the community report conflicting percentages, ranging from 56%17 to 74%18. The genetic influence seems to have more relevance in men than in women whose prevalent risk factor is the socio-cultural environment19. Linkage studies on families presenting an aggregation of AN cases were addressed to identify specific “candidate genes” giving to carriers a susceptibility to the disease. Results from these studies showed the involvement of genes located on chromosome 1 (locus 1p34.3-36.3, locus 1q41) and chromosome 11 (locus 11q22) in AN cases, and genes located on chromosome 10 (locus 10p13) and on chromosome 14 (locus 14q22.2-23.1) in BN cases. Chromosome 1 seems to be also involved in subjects with behavioral traits, not frankly pathological, related to anorexia (locus1q31.3)20.

A second type of molecular approach is represented by studies concerning association effects, focused on the analysis of polymorphic variants of many genes whose products regulate energy homeostasis and eating behavior. In detail, neurotransmitters (serotonin, opioid, cannabinoid, dopaminergic, cholinergic system), endocrine peptides (leptin, ghrelin, insulin), hypothalamic neuropeptides (NPY, COMT, AgRP), cerebral neurotrophic factors (BDNF), specific receptors for serotonin (HTR1D and HTR2A), for dopamine (DRD4), for opioid (OPRD1), for cannabinoid (CNR1) and carriers of serotonin (HTTLPR), of norepinephrine (NET) resulted to be involved in AN, even if scientific reports on this topic were not always specific and concordant21.

The identification of polymorphic variants could suggest, on the one hand, the possibility of identifying endo-phenotypes at risk22, but on the other the associated dysfunctional neuronal mechanisms often persist even after the remission of anorexic behavior23. Therefore, it is difficult to establish whether these associations are pre-existing to the disorder and therefore causal, or if they are consequential, or occasional, linked to comorbidities with other inheritable disorders such as obsessive-compulsive disorder, major depression and generalized anxiety24.

The molecular mechanisms by which genes contribute to promote the onset of eating disorders are not entirely known. Genome-wide association studies (GWAS), carrying out genomic analysis through microsatellite DNA markers, have allowed to analyze, in candidate loci, the polymorphic variants of single nucleotides (SNPs). As a result, 10 new microsatellite markers, of which 7 associated with AN, were identified in new susceptible loci: 1p36, 1q41, 5q15, 11q13, 11q22, 16q12 and 18q2220.

Despite the frequent detection of specific SNPs in subjects affected by AN, their association with the clinical expression of the disease has been inconclusive. Actually the morbid event is not related to a single gene variation, in itself, but rather to the overall effect on the expression of other genes involved in the development of the pathological phenotype. Thereby the etiological role of genetics in anorexia should be considered as the result of a complex polygenic action, always interacting with intra-uterine and/or environmental epigenetic effect.

In AN, methylation was especially demonstrated to involve promoters of genes regulating dopamine system, the biosynthesis of vasopressin and atrial natriuretic peptide25,26. In anorexic patients resistant to therapy an altered dopaminergic response to fasting was observed in neurons of the ventral tegmental mesolimbic area connected to nucleus accumbens (the striatal reward system), likely due to genetic polymorphisms or DNA methylation in the intrauterine or extrauterine environment27. It is also known that nutrients may alter gene expression through an epigenetic process, so generating the idea that the genetically determined response to some food components may promote susceptibility to eating disorders. These data suggest the possibility of a nutraceutical intervention associated to pharmacologic and psychiatric treatment.

Sex steroids

The expression of genes regulating energy homeostasis is controlled by a specific transcriptional action of sex steroids, whose pathogenic role as “risk factors” of ED had already been suggested by epidemiological data. The role of androgens in the initiation and/or clinical manifestation of male anorexia is currently being investigated. Since the prenatal period, starting from the seventh week of intrauterine development, exposure to maternal and fetal testosterone is critical for the permanent and irreversible morpho-functional organization of brain and adipose tissue. In fact the prenatal exposure to testosterone plays a crucial action by inducing a sexually dimorphic imprinting on brain areas in development, functionally related to hunger and satiety control, as well as on neuronal circuits involved in reward mechanisms and attitudes towards food, and finally on the regulation of energy metabolism and body weight28.

In the male fetus, the androgenization program promotes a greater neuronal extension in the hypothalamus (anterior preoptic area, vasoactive intestinal peptide, VIP-expressing neuron of the sovrachiasmatic nucleus, interstitial nuclei 2-3 of the human anterior hypothalamus, pre-mammillary nucleus), amygdala, insula, and cingulate orbital-frontal cortex29.

Furthermore, androgens are involved in the regulation of the melanocortin system in arcuate nucleus, by decreasing neurogenesis and distribution of first-order pro-opiomelanocortin (POMC) neurons, the expression and the release of the POMC peptides, the action of various neurotransmitters involved in the reduction of food intake. Finally, it promotes in the anterior periventricular nucleus the inhibitory action of somatostatin on anorexic POMC neurons.

This complex morpho-functional organization leads to an orexic-oriented attitude and metabolic anabolism, therefore high prenatal androgen exposure is associated with a reduced incidence of ED30. However, the androgenic effect does not only depend on the hormonal level, but also on its receptor’s sensitivity, which is genetically determined since it is inversely proportional to the length of the Cytosine Adenine Guanine (CAG) repeated sequences in the gene of fetal androgen receptor, located on chromosome X30. The same concentration of androgens can therefore influence in a different way the dimorphic differentiation of embryo-fetal tissues during their development31.

In summary, susceptibility to ED, modulated through the maternal level of androgens, as well as by the expression of fetal receptors for androgens, can be due to a transgenerational transmission32. In some districts, the organizational androgenic effect does not occur in the fetal stage, but acquires significance only after birth: this is the case, for example, of the bed nucleus of the stria terminalis (BST) – an important station along the efferent circuit from basolateral amygdala to the hypothalamus – whose dimensions are dimorphic and directly related to the amount of testosterone. During pubertal development and in adulthood, the postero-medial portion of the nucleus (BST-dspm) is more extended in the male by about 2.5 times33, while in the central part of the core (BSTc), the number of somatostatinic neurons is greater than about 44%.

For these reasons, the activation of BST is easier in men than in women and involves the “switching off” of glutamatergic hypothalamic neurons, with an increased drive towards food even when the energy balance does not stimulate food intake34. After birth, steroid effect, mostly reversible, will be activated in the post-pubertal period: androgens will continue lifelong to define a “male phenotype” by modulating the biochemical processes involved in the balance between food intake and energy expenditure, with a final anabolic effect.

Testosterone acts on body composition leading to a lean mass >75% and fat mass <25%, on fat distribution (hypertrophy of adipose subcutaneous, especially visceral, abdominal tissue), on adipocyte metabolism through inhibition of adipogenesis and finally on myogenesis by promoting the differentiation of myotubules and myofibrils. Moreover, testosterone modulates the expression of neuroendocrine peptides by increasing ghrelin -orexigenic-, and reducing insulin and leptin -appetite suppressants-, thus stimulating food intake and increasing the number of meals35. Finally, it maintains high energy expenditure which promotes food intake, increases the basal metabolic rate, muscle activity, thermogenesis, lipid mobilization and oxygen consumption.

In summary, a physiological androgenic phenotype, progressively delineated, will be mostly protective against the development of anorexia. Nevertheless, the masculine phenotype is subject to change and becomes more exposed to the disease according to different androgenic receptor profiles19.

Protection from anorexia has been demonstrated in the early stages of adolescence and young adulthood, but not in late adolescence: males’ susceptibility during this period is actually influenced by unknown interfering factors, which reduce the androgenic protection and determine a “shift” toward a phenotype more at risk of AN.

In conclusion, genetics undoubtedly plays a significant role in the development of eating disorders, but unfortunately most studies have not investigated the influence of gender on genetic factors. More research is needed to understand the complex relationship between genetic, hormonal, neuronal and psychosocial development of male AN.

Focus on leptin and its relation with hypothalamic pituitary axis: the paradox of AN

Leptin, a hormone secreted by white adipose tissue, plays an important role in regulating body weight and in the activation of the hypothalamic-pituitary gonadal axis, both in animals and in humans of both sexes.

Leptin signals reach hypothalamus to inform it on the amount of body fat so that drive for eating can be up or down modulated within a negative relation with adiposity. The decrease of fat mass, typical of anorexia in both genders but particularly significant in males, due to a minor physiologic percentage of adiposity in comparison with females, should increase, through a low leptin level, the drive for eating but paradoxically this adaptive mechanism is not effective in promoting food intake in anorexia36.

Leptin also plays an important role in regulating neuroendocrine function and controlling the onset of puberty. Severe leptin deficiency is associated with hypogonadotrophic hypogonadism; it has been reported that a critical level of leptin37 and a leptin signal is essential for achieving puberty through the increase of gonadotropins, a key element for a full pubertal development in boys38 as well as in girls39,40. Females who are carriers of genetic mutations resulting in leptin or leptin receptors biologically inactive, have primary amenorrhea41,42 and pubertal development is restored by the administration of leptin in replacement doses43-45.

Adolescents with AN have low levels of leptin, predictive of secondary amenorrhea46.

The weight gain induced by refeeding is accompanied by increases in luteinizing hormone (LH) levels and progressive achievement of a “threshold” level of leptin under which the “trigger” mechanism on the resumption of the menstrual cycle is not activated47.

Males do not have an equivalent on/off response –such as presence/absence of the menstrual cycle related through leptin to the nutritional status.

Nevertheless, it has been demonstrated that caloric deprivation in normal weight males decreases testosterone levels and LH pulsatility; these effects are reversible after administration of physiological doses of leptin48,49. On the contrary, the increase in leptin concentrations related to weight recovery seems positively correlated to gonadotropins and testosterone increases50. Leptin influences the secretion of LH through indirect pathways since the neurons responsible for synthesis and release of pituitary gonadotropins (GnRH) do not have leptin receptors51. Males with AN, similarly to anorexic females, may present disorders of the hypothalamus-pituitary-gonadal axis resulting in lower circulating levels of testosterone than healthy controls52.

Compulsive exercise, one of the compensative methods most used by anorexic males, can be a contributory cause of secondary hypogonadism, by reducing circulating levels of LH and testosterone53.

Excessive exercise is associated to a decrease in libido, muscle weakness, sleep disturbances, low mood54 and also to a reduced semen quality and increased prolactin levels55. It has been reported that the recovery of a normal hypothalamic-pituitary-gonadal axis function in males affected by anorexia will occur after at least two years since the restoration of a safe body weight, in the presence of a normal lean to fat mass ratio. In the same time range, mood and libido will be recovered without any medication intake53.

Environmental risk factors

The scientific literature emphasizes the fact that individuals who have a genetic predisposition as well as risk factors for an ED may actually develop an ED as a result of any precipitating event.

Some risk factors for developing an ED are similar in both genders: a previous presence of overweight and/or obesity, especially if repeatedly treated through restrictive diets, the presence of traumatic events in the personal history, low self-esteem or body discomfort and finally psychiatric comorbidities56.

Overweight and obesity seem nevertheless to be more prevalent in the premorbid history of men than in women.

Sports that require weight control and consequently controlled feeding such as horseback riding, skating or boxing are also risk factors57. It is actually doubtful whether sexual orientation may be considered a risk factor for AN: at regards literature data are still inconsistent58.

The role of the family is very important, especially in adolescents, particularly when weight and nutrition are central topics at home or when an ED is present in the family: in these cases, even in males, the development of an ED can be facilitated.

The presence of substance abuse or psychiatric disorders, such as depression, can be considered as a risk factor in both sexes, but psychiatric comorbidity seems to be more severe (psycosis, major depression) and frequent in males.

Some of the precipitating factors, especially in adolescence, include teasing by peers about weight or physical fitness, distressing life events such as separation from partners, or school difficulties.

Clinical manifestations: psychopathological and medical aspects

AN symptoms are mostly similar in both genders59, but males often present more severe complications at first observation than females, since they usually ask for a treatment at a more advanced stage of the disease60. It is argued that, in males, the interval between the onset of a restrictive AN and the beginning of treatment is on average one year, and four years in purging AN.

As regards the age of onset of AN, it seemed to be higher in males than in females according to one research on hospitalized patients, not otherwise confirmed by other studies61. In an early review of AN in males Crisp62 did not report any difference, while, more recently the average age of onset of anorexia in males has been reported around 18.6 yrs, one year older than in females, in relation to puberty, the period more at risk for the onset of ED, occurring later in boys than in girls63.

As concerns the values of premorbid BMI a recent review indicates a more frequent condition of overweight in males and in general a higher BMI at diagnosis7.

Males affected by AN suffer from the same core psychopathological symptoms as females, i.e. a profound body image distortion and a consequent drive for thinness. Their body misperception is mainly focused on abdomen and thighs but often, differently from females, even on the chest. In fact muscularity, particularly focused on shoulders and trunk, may be of great concern besides thinness6.

Weight decrement in males is mainly achieved by controlling the introduction of calories and physical hyperactivity rather than by using evacuative methods, such as self-induced vomiting or use of laxatives. More frequent physical hyperactivity and less frequent laxative and diuretic use are actually observed in males with anorexia compared to females64,65. Compulsive resistance exercise (marathon, swimming) is in fact the prevalent compensative behavior in males, probably because it is perceived as more socially acceptable and may be a less distressing symptom.

It is possible that females may come to clinical attention sooner because they have a greater variety of behavioral symptoms, both purgative, more distressing and earlier detected than in males, and not purgative such as compulsive exercise, like males66.

Obsessive calorie control may persist despite weight recovery.

Lastly, a brief mention should be reserved to a disturbance – body dysmorphia – mainly present in males, and in particular in body-builders, characterized by an obsessive focus on muscularization and body definition. Body dysmorphia, while sharing with ED an inappropriate focus on the body, food control and excessive exercise – often associated with anabolic steroid abuse – and altered psychic and relational functioning, has always been classified as an obsessive disorder and this position was confirmed in the DSM-5 as well.

Medical complications

AN, in both sexes, is the most severe ED because of the great variety and relevance of medical complications potentially affecting each organ and system67.

Medical complications can be more or less serious and more or less reversible after recovery, depending on the degree of malnutrition, its duration, the rapidity of weight loss and the type of compensative behavior used to lose weight (purgative practices, intense and compulsive exercise, fasting) (Table 1). The adaptive homeostatic response to malnutrition, consisting of reducing energy consumption by means of increasing vagal activity and decreasing active triiodothyronine, may in turn, have a negative effect on the cardiovascular system, such as severe bradycardia and syncope67.

For decades, a wide range of studies has been addressed towards female anorexia for the well-known epidemiological reasons, but many papers have been published in recent years on male anorexia: these studies, sometimes conflicting, sometimes inhomogeneous in the selection of samples (general population or clinical population) still stimulate researchers to think over some points, not completely clarified, concerning the specificity of male anorexia and its differences from female anorexia also from the internist’s point of view.

In discussing this topic, we will try to answer some of these questions.

Do males suffer from the same medical consequences of anorexia as females? The anorexic subjects who reach a state of severe malnutrition have no clinically significant gender differences: Crisp et al. say “The disorder sadly and radically diminishes the differences between the sexes so than is the case with any other functional mental illness”65.

But, if we step back from severe malnutrition and its consequences, which seem to decrease gender differences, we have partially conflicting information: on the one hand, some papers report a substantial similarity in clinical presentation, symptoms, medical complications, and prognosis of the disease in both sexes59,68.

On the contrary, other papers report under diagnosis and under treatment69, persistent difficulties in recognizing and diagnosing anorexia in males leading to a delayed diagnosis and a consequent worse disease at the first observation70.

According to the latest studies, diagnostic delay and severe medical conditions at diagnosis have also been observed by the authors in a small sample of anorexic males treated at the ED Unit of Ferrara3.

In the interpretation of these data, it is important to evaluate how much the reported differences are due to the inadequacy of diagnostic tools (DSM-4, tests and questionnaires) for male subjects or, on the contrary, due to a really different susceptibility of males to malnutrition and compensative behaviors.

Regarding the first point, the diagnostic criteria of DSM-4 for anorexia applied till 2013 established diagnostic values of weight and BMI too low for males*71 with a consequent prevalence of EDNOS diagnosis.

In our recent research, male cases classified at first as EDNOS according to DSM-4 were burdened by a wide number of medical complications and, once the more inclusive and flexible DSM-5 criteria were applied, they were reclassified as full AN72.

In male anorexia, the weight trend over the past year could be of greater diagnostic significance than an absolute BMI value at first observation, particularly in previously overweight males. Furthermore the absence of a symptom “on-off” similar to amenorrhea – which indicates a not healthy weight in females – makes it difficult to determine the minimum healthy BMI in males.

Finally, in presence of hypogonadism, even a significant weight decrease is not initially present in a visible way in males, due to the relative increase in fat mass compared to lean mass73.

These gender-diagnostic biases have made it difficult to make a reliable comparison by gender of the state of malnutrition and consequent clinical manifestations.

In their 200271 overview, Woodside et al. also suggest that the lack of significant differences of the disease in men and women is due to the prevalent use of clinical samples where the severity of anorexia tends to eliminate differences by gender, while studies on the general population might point out real gender differences.

To answer this first question, whether clinical differences are present in the two genders, it is necessary to wait the results of studies comparing wide samples of both genders, from general and clinical population, classified according to DSM-5 criteria.

Is there a different susceptibility to malnutrition in males compared with females? In analyzing this point, it should be remembered that at the end of puberty fat mass is around 12% in males while it is about 25%7 in females, therefore fat mass decrease in anorexic males reaches a critical level earlier than in females, leading to earlier ketosis and protein breakdown67. Furthermore, in physiological conditions, pubertal development in males is longer than in females so that their bones have a greater linear growth and a greater bone mass compared with females. In adolescent males, AN could stop the growth and bone accrual and consequently cause more severe complications regarding growth and bone density than in females.

So, in general, medical complications in the two sexes are not substantially different unless the disease occurs during the early phase of pubertal development. In this case, the decrease in bone density and failure to achieve the expected stature primarily affect males as their potential for growth persists longer than two years compared to females74-77.

In recent decades, several authors have reported growing evidence of bone mineral loss in males with anorexia and bulimia78,79: in particular, in a study in patients hospitalized for anorexia, Mehler reported a higher prevalence of osteopenia (36%) and osteoporosis (26%) in males than in females with AN. Males and females were not significantly different with respect to a number of parameters such as BMI, age of hospitalization, duration of hospitalization and diagnostic category, but they had a different disease duration, shorter in males. Low BMI and long disease duration were negative predictors, while low testosterone levels were not associated with an increased risk of osteopenia78. According to the same study, men with osteopenia and osteoporosis also had a higher risk of fractures than females.

Many recent studies addressed the complex relationships between bone and fat tissue in its different components, subcutaneous white adipose tissue and visceral (WAT), brown adipose tissue (BAT), and bone marrow adipose tissue (BMAT), highlighting that such compartments have an impact, to a different extent, on variations of bone density. Among these compartments, the bone marrow adipose tissue is the most involved in bone changes and its increase is negatively related to aging bone loss, menopause and other metabolic conditions including AN, so that it has become a reliable marker of bone integrity80. The bone marrow compartment in fact represents a quite peculiar situation, a niche where mesenchymal stem cells (MSCs), a multipotent non-hematopoietic stem cell population, can differentiate towards the osteoblast or, on the contrary, to the bone marrow adipocyte according to a variety of stimulations81,82.

Many factors such as hypercortisolemia and hypoestrogenism, typical hormonal alterations of anorexia, have been shown to interfere with adipo-osteogenic balance by promoting the differentiation of mesenchymal stem cells into adipocytes to the disadvantage of osteoblasts, thus decreasing bone density83,84.

No data are currently available about a gender dimorphism in this adipo-osteogenic differentiation of MSCs, even though the different composition and distribution of adipose tissue in the male both in physiological conditions and in pathological conditions such as anorexia could suggest it85.

Are males’ cardiovascular complications and mortality similar to those of females? Among the medical complications of AN, cardiovascular alterations are of primary importance since they are considered responsible for about half of the deaths in anorexic subjects (Table 2). Therefore, they should be deeply investigated, correctly diagnosed and monitored according to the APA guidelines3. A clear evidence of gender differences in this area is not currently available given that so far the majority of research has been focused, on females.

Nevertheless, electrocardiographic and electrophysiological differences by gender in the general population are very well known and mainly attributed to hormonal factors. In physiological conditions, women have a higher heart rate at rest due to a combination of autonomic and intrinsic factors, a longer QTc and a shorter recovery time of the sinus node compared to men. Cardiovascular sudden death, on the other hand, has a higher incidence in men than in premenopausal women who, by virtue of estrogen protection, have later onset of coronary heart disease, if compared with males.

Cardiovascular complications of AN can be caused either by an excessive vagal response and a decrease of thyroid function, representing a homeostatic response to weight loss, or by a direct damage of malnutrition on the myocardial tissue, or by electrolyte abnormalities.

Bradycardia, hypotension, and QTc prolongation interval exceeding 460 msec have been reported in anorexia85,86. Main risk factors of sudden death in ED seem to be duration of illness (>10 years), chronic hypokalemia, plasmatic albumin chronically <3.6 g/100 mL and absolute QT ≥600 msec)87. QTc prolongation is usually associated with sudden ventricular arrhythmias and death88. In males, resistance compulsive exercise may worsen bradycardia associated to undernutrition and constitute a further risk factor for cardiovascular complications in bradycardic subjects.

Course and prognosis

AN prognosis is poor in 20-25% of patients who go towards chronicization and a high mortality rate, the highest among psychiatric diseases, ranging from 5 to 10% and a relative risk of death higher by 30 times than peers in the year of diagnosis89-92. Mortality is mostly due to medical complications of starvation93.

Mortality has been reported by many authors as not substantially different in the two genders6,56,62. In both genders, long duration of the disease is related to a worse prognosis so that an early diagnosis is a crucial step to receive adequate early treatment and a good prognosis in both sexes70. A higher age at diagnosis, chronicity and a low BMI at first consultation are related, as in females, with higher mortality.

Nevertheless, some differences have been reported in recent years.

Psychiatric comorbidity, more prevalent in males than in females, is a negative prognostic factor that increases the standardized mortality rate from 4.1% up to 9.1%94,95.

In addition, a study run in the United States on the use of medical facilities by ED patients showed that males received less treatment than females and, when treated, they had fewer days of hospitalization96.

A higher rate of mortality in men than in women has been reported in the long term5; furthermore, in a research on 23 hospitalized subjects, anorexic males had a higher mortality rate than females only a short time after discharge59.


* When using body mass index (BMI), a higher BMI should be used for defining normal in men, most often between 22 and 27, than for women, where 20 to 25 is the standard. While there is no uniform agreement on the BMI that qualifies for a diagnosis of anorexia, most clinicians use an index of 17.5 for women and 19-19.5 for men.


1. Fairburn CG, Cooper Z. Thinking afresh about the classification of eating disorders. Int J Eat Disord 2007; 40: S107-S110.

2. Attia E, Roberto CA. Should amenorrhea be a diagnostic criterion for anorexia nervosa? Int J Eat Disord 2009; 42: 581-9. doi:10.1002/eat.20720.

3. APA. Practice guideline for the treatment of patients with eating disorders. APA 3rd Edition 2006.

4. Manzato E, Strumia R, Gualandi M, et al. Eating disorders in males. New York: Nova Science Publisher, 2008.

5. Zhang C. What can we learn from the history of male anorexia nervosa? J Eat Disord 2014; 2: 138. doi 10.1186/s40337-014-0036-9.

6. Raevuori A, Keski Rahkonen A, Hoek HW. A review of eating disorders in males. Curr Opin Psychiatry 2014; 27(6): 426-30.

7. Raevuori A, Hoek HW, Susser E, et al. Epidemiology of anorexia nervosa in men: a nationwide study of Finnish twins. PLoS ONE 2009; 4(2):e4402.

8. Quaderni del Ministero della Salute. Appropriatezza clinica, strutturale e operativa nella prevenzione, diagnosi e terapia dei Disturbi dell’Alimentazione. N. 17/22, luglio-agosto 2013.

9. Qian J, Hu Q, Wan Y, et al. Prevalence of eating disorders in the general population:a systematic review. Shanghai Arch of Psychiatr, 2013; 25(4): 213-23.

10. Sweeting H, Walker L, MacLean A, et al. Prevalence of eating disorders in males: a review of rates reported in academic research and UK mass media. Int J Men’s Health 2015; 4: 86-112.

11. Mitchison D, Mond J. Epidemiology of eating disorders, eating disordered behaviour, and body image disturbance in males: a narrative review. J Eat Disord 2015; 3: 20. doi 10.1186/s40337-015-0058-y.

12. Le Grange D, Swanson SA, Crow SJ, et al. Eating disorder not otherwise specified presentation in the US population. Int J Eat Disord 2012; 45(5): 711-8.

13. King MB. Eating disorders in a general practice population: prevalence, characteristics and follow-up at 12 to 18 months. Psychol Med (Monogr. Suppl.) 1989; 14, 1-34.

14. Räisänen U, Hunt K. The role of gendered constructions of eating disorders in delayed help-seeking in men: a qualitative interview study. BMJ Open 2014; 4:e004342.

15. MacLean A, Sweeting H, Walker L, el al. “It’s not healthy and it’s decidedly not masculine”: a media analysis of UK newspaper representations of eating disorders in males. BMJ Open 2015; 5:e 007468. doi:10.1136/bmjopen-2014-007468.

16. Darcy AM, Celio Doyle A, Lock J, et al. The eating disorders examination in adolescent males with anorexia nervosa: how does it compare to adolescent females? Int J Eat Disord 2012; 45(1): 110-4. doi:10.1002/eat.20896.

17. Bulik CM, Sullivan PF, Tozzi F, et al. Prevalence, heritability, and prospective risk factors for anorexia nervosa. Arch Gen Psychiatry 2006; 63: 305-12.

18. Klump KL, Wonderlich S, Lehoux P, et al. Does environment matter? A review of nonshared environment and eating disorders. Int J Eat Disord 2002; 31: 118-35.

19. Baker JH, Maes HH, Lissner L, et al. Genetic risk factors for disordered eating in adolescent males and females. J Abnorm Psychol 2009; 118(3): 576-86.

20. Nakabayashi k, Komaki G, Tajima A, et al. Identification of novel candidate loci for anorexia nervosa at 1q41 and 11q22 in Japanese by a genome-wide association analysis with microsatellite markers. J Hum Genet 2009; 54: 531-7.

21. Scherag S, Hebebrand J, Hinney A. Eating disorders: the current status of molecular genetic research. Eur Child Adolesc Psychiatry 2010; 19(3): 211-26. Epub 2009, Dec24.

22. Treasure JL Getting beneath the phenotype of anorexia nervosa: the search for viable endophenotypes and genotypes. Can J Psychiatry 2007; 52: 212-19.

23. Wierenga CE, Ely A, Bischoff-Grethe A, et al. Are extremes of consumption in eating disorders related to an altered balance between reward and inhibition? Front Behav Neurosci 2015; 8: 410.

24. Södersten P, Berg C, Leon M, et al. Dopamine and anorexia nervosa. Neurosci Biobehav Rev 2016, 60: 26-30.

25. Frieling H, Bleich S, Otten J, et al. Epigenetic downregulation of atrial natriuretic peptide but not vasopressin mRNA expression in females with eating disorders is related to impulsivity. Neuropsychopharmacology 2008; 33: 2605-9.

26. Frieling H, Römer KD, Scholz S, et al. Epigenetic dysregulation of dopaminergic genes in eating disorders. Int J Eat Disord 2010; 43(7): 577-83. doi: 10.1002/eat.20745.

27. O’Hara CB, Campbell IC, Schmidt U. A reward-centred model of anorexia nervosa: a focused narrative review of the neurological and psychophysiological literature. Neurosci Biobehav Rev 2015; 52: 131-52.

28. Lombardo MV, Ashwin E, Auyeung B, et al. Fetal programming effects of testosterone on the reward system and behavioral approach tendencies in humans. Biol Psychiatry 2012a; 72:839-47.

29. Culbert KM, Breedlove SM, Sisk CL, et al. The emergence of sex differences in risk for disordered eating attitudes during puberty: a role for prenatal testosterone exposure. J Abnorm Psychol 2013; 122: 420-32.

30. Smith AR, Hawkeswood SE, Joiner TE. The measure of a man: associations between digit ratio and disordered eating in males. Int J Eat Disord 2010; 43: 543-8.

31. Chamberlain NL, Driver ED, Miesfeld RL. The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acids Res 1994; 22: 3181-6.

32. Patterson MN, McPhaul MJ, Hughes IA. Androgen insensitivity syndrome. Baillières Clin Endocrinol Metab1994; 8: 379-404.

33. Wilson C, Chung J, De Vries GJ, et al. Sexual differentiation of the bad nucleus of the stria terminalis in himans may extend into adulthood. J Neurosci 2002; 22(3): 1027-33.

34. Jennings JH, Rizzi G, Stamatakis AM, et al. The inhibitory circuit architecture of the lateral hypothalamus orchestrates feeding. Science 2013; 341(6153): 1517-21.

35. Baker JH, Girdler SS, Bulik CM. The role of reproductive hormones in the development and maintenance of eating disorders. Expert Rev Obstet Gynecol 2012; 7: 573-83.

36. Galusca B, Prévost G, Germain N, et al. Neuropeptide Y and α-MSH circadian levels in two populations with low body weight: anorexia nervosa and constitutional thinness. PLoS ONE 2015; 10(3):e0122040. doi:10.1371/journal.pone.0122040.

37. Matkovic V, Ilich JZ, Skugor M, et al. Leptin is inversely related to age at menarche in human females. J Clin Endocrinol Metab 1997; 82: 3239-45.

38. Mantzoros CS, Flier JS, Rogol AD. A longitudinal assessment of hormonal and physical alterations during normal puberty in boys. V. Rising leptin levels may signal the onset of puberty. J Clin Endocrinol Metab 1997; 82: 1066-70.

39. Blum WF, Englaro P, Hanitsch S, et al. Plasma leptin levels in healthy children and adolescents: dependence on body mass index, body fat mass, gender, developmental stage and testosterone. J Clin Endocrinol Metab 1997; 82: 2904-10.

40. Garcia-Mayor RV, Andrade MA, Rios M, et al. Serum leptin levels in normal children: relationship to age, gender, body mass indexc, pituitary-gonadal hormones and pubertal stage. J Clin Endocrinol Metab 1997; 82: 2849-55.

41. Clement K, Vaisse C, Lahlou N, et al. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 1998; 392: 398-401.

42. Strobel A, Issad T, Camoin L, et al. A leptin missense mutation associated with hypogonadism and morbid obesity. Nat Genet 1998; 18: 213-5.

43. Farooqi IS, Jebb SA, Langmack G, et al. Effects of recombinant leptin therapy in a child with congenital leptin deficiency. N Engl J Med 1999; 341: 879-84.

44. Farooqi IS, Matarese G, Lord GM, et al. Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. J Clin Invest 2002; 110: 1093-103.

45. Paz-Filho G, Delibasi T, Erol HK, et al. Congenital leptin deficiency and thyroid function. Thyroid Res 2009; 2:11.

46. Köpp W, Blum WF, von Prittwitz S, et al. Low leptin levels predict amenorrhea in underweight and eating disordered females. Mol Psychiatry 1997; 2: 335-40.

47. Ballauff A, Ziegler A, Emons G, et al. Serum leptin and gonadotropin levels in patients with anorexia nervosa during weight gain. Mol Psychiatry 1999; 4: 71-5.

48. Chan JL, Heist K, DePaoli AM, et al. The role of falling leptin in the neuroendocrine and metabolic adaptation to short-term starvation in healthy men. J Clin Invest 2003; 111: 1409-21.

49. Chan JL, Wong SL, Mantzoros CS. Pharmacokinetics of subcutaneous recombinant methionyl human leptin administration in healthy subjects in the fed and fasting states: regulation by gender and adiposity. Clin Pharmacokinet 2008; 47: 753-64.

50. Wabitsch M, Ballauff A, Holl R, et al. Serum leptin, gonadotropin, and testosterone concentrations in male patients with anorexia nervosa during weight gain. J Clin Endocrinol Metab 2001; 86: 2982-8.

51. Quennell JH, Mulligan AC, Tups A, et al. Leptin indirectly regulates gonadotropin-releasing hormone neuronal function. Endocrinology 2009; 150: 2805-12.

52. Tomova A, Kumarov P. Sex differences and similarities of hormonal alterations in patients with anorexia nervosa. Andrologia 1999; 31: 143-7.

53. Cazzuffi A, Manzato E, Gualandi M, et al. Young man with anorexia nervosa. J R Soc Med Sh Rep 2010; 1: 39-41.

54. Woodhill I, Cooper C, Zacharin M, et al. Low testosterone in a male adolescent bodybuilder: which diagnosis holds more weight? J Paed Child Health 2014; 50: 739-41.

55. Safarinejad MR, Azma K, Kolahi AA. The effects of intensive, long-term treadmill running on reproductive hormones, hypothalamus-pituitary-testis axis, and semen quality: a randomized controlled study. J Endocrinol 2009; 200: 259-71.

56. Carlat DJ, Camargo CA Jr, Herzog DB. Eating disorders in males: a report on 135 patients. Am J Psychiatry 1997; 154: 1127-32.

57. Baum A. Eating disorders in the male athlete. Sports Med 2006; 36(1): 1-6.

58. Feldman MB, Meyer IH. Eating disorders in diverse lesbian, gay, and bisexual populations. Int J Eat Disord 2007; 40: 218-26.

59. Gueguen J, Godart N, Chambry J, et al. Severe anorexia nervosa in men: comparison with severe AN in women and analysis of mortality. Int J Eat Disord 2012; 45(4): 537-45.

60. Vandereycken W, Broucke S. Anorexia nervosa in males. Acta Psychiatr Scand 1984; 70: 447-54.

61. Welch E, Ghaderi A, Swenne I. A comparison of clinical characteristics between adolescent males and females with eating disorders BMC Psychiatry 2015; 15:45. doi 10.1186/s12888-015-0419-8

62. Crisp AH, Burns T, Bhat AV. Primary anorexia nervosa in the male and female, a comparison of clinical features and prognosis. Br J Med Psychol 1986; 59: 123-32.

63. Forman-Hoffman VL, Watson TL, Andersen AE. Eating disorders age of onset in males: distribution and associated characteristics. Eat Weight Disord 2008; 13: 28-31.

64. Braun DL, Sunday SR, Huang A, et al. More males seek treatment for eating disorders. Int J Eat Disord 1999; 25: 415-24.

65. Fichter M, Krenn H. Eating disorders in males. In: Treasure J, Schmidt U, van Furth E. (eds) Handbook of Eating Disorders, 2nd edn John Wiley & Sons England, 2003.

66. Shu C Y, Limburg K, Harris C, et al. Clinical presentation of eating disorders in young males at a tertiary setting. J Eat Disord 2015; 3:39.

67. Mehler PS, Brown C. Anorexia nervosa – medical complications. Int J Eat Disord 2015; 3: 11. doi:10.1186/s40337-015-0040-8.

68. Carlat DJ, Camargo CA, Jr, Herzog DB. Eating disorders in males: a report on 135 patients. Am J Psychiatry 1997; 154: 1127-32.

69. Strother E, Lemberg R, Stanford SC, et al. Eating disorders in men: underdiagnosed, undertreated, and misunderstood. Eat Disord 2012; 20(5): 346-55.

70. Siegel HJ, Hardoff D, Golden NH, et al. Medical complications in male adolescent with anorexia nervosa. J Adolesc Health 1993; 16: 448-53.

71. Woodside DB. Eating disorders in men: an overview. Healthy Weight Journal 2002; 16(4): 6-9.

72. Gualandi M, Simoni M, Manzato E, et al. Reassessment of patients with eating disorders after moving from DSM-4 towards DSM-5: a retrospective study in a clinical sample. Eat Weight Disord 2016; (4): 617-24. doi 10.1007/s40519-016-0314-4.

73. Andersen AE. Eating disorders: a guide to medical care and complications. In: Mehler MS, Andersen AE, editors. Males with eating disorders: Medical considerations. Baltimore: Johns Hopkins University Press 1999; 214-25.

74. Misra M. Long-term skeletal effects of eating disorders with onset in adolescence. Ann N Y Acad Sci 2008; 1135: 212-8.

75. Misra M, Katzman DK, et al. Bone metabolism in adolescent boys with anorexia nervosa. J Clin Endocrinol Metab 2008; 93(8): 3029-36.

76. Modan-Moses D, Yaroslavsky A, Novikov I, et al. Stunting of growth as a major feature of anorexia nervosa in male adolescents. Pediatrics 2003; 111(2): 270-6.

77. Danziger Y, Mukamel M, Zeharia A, et al. Stunting of growth in anorexia nervosa during the prepubertal and pubertal period. Isr J Med Sci 1994; 30: 581.

78. Mehler PS, Sabel A L,Watson T, et al. High risk of osteoporosis in male patients with eating disorders. Int J Eat Disord 2008; 41:666-672.

79. Andersen EA, Watson T, Schlechte J. Osteoporosis and osteopenia in men with eating disorders. Lancet 2000; 355: 1967-68.

80. Hardouin P, Rharass T, Lucas S. Bone marrow adipose tissue: to be or not to be a typical adipose tissue? Front Endocrinol 2016; 30: 7-85.

81. Chen Q, Shou P, Zheng C, et al. Fate decision of mesenchymal stem cells: adipocytes or osteoblasts? Cell Death and Differentiation 2016; 23(7): 1128-1139. doi:10.1038/cdd.2015.168.

82. Bredella MA, Fazeli PK, Daley SM, et al. Marrow fat composition in anorexia nervosa. Bone 2014; 66:199-204. doi:10.1016/j.bone.2014.06.014.

83. Faje A, Klibanski A. Body composition and skeletal health: too heavy? Too thin? Curr osteoporos Rep 2012; 10(3): 208-16. doi: 10.1007/s11914-012-0106-3.

84. El Goch M, Calugi S, Lamborghini S, et al. Anorexia nervosa and body fat distribution. A systematic review. Nutrients 2014; 6: 3895-3912.

85. Misra M, Aggarwal A, Miller KK, et al. Effects of anorexia nervosa on clinical, hematologic, biochemical and bone density parameters in community- dwelling adolescent girls. Pediatrics 2004; 114(6): 1574-83.

86. Isner JM, Roberts WC, Heymsfield SB, et al. Anorexia nervosa and sudden death. Ann Intern Med 1985; 102: 49-52.

87. Jáuregui-Garrido B, Jáuregui-Lobera I. Sudden death in eating disorders. Vasc Health Risk Manag 2012; 8: 91-8. doi: 10.2147/VHRM.S28652.

88. Niemeijer MN, van den Berg ME., Deckers JW, et al. Consistency of heart rate–QTc prolongation consistency and sudden cardiac death: the Rotterdam study. Heart Rhythm 2015; 12(10): A1-A16. e121-e136, 2047-2206.

89. Nielsen S. Epidemiology and mortality of eating disorders. Psychiatr Clin North Am 2001; 24(2): 201-14.

90. Steinhausen HC. The outcome of anorexia nervosa in the 20th century. Am J Psychiatry 2002; 158(8): 1284-93.

91. Arcelus J, Mitchell A, Wales J, et al. Mortality rates in patients with anorexia nervosa and other eating disorders: a meta-analysis of 36 studies. Arch Gen Psychiatry 2011; 68(7): 724-31.

92. Harris EC, Barraclough B. Excess mortality of mental disorder. Br J Psychiatry 1998; 173: 11.

93. Fichter MM, Quadflieg N. Mortality in eating disorders - results of a large prospective clinical longitudinal study. Int J Eat Disord 2016; 49(4): 391-401. doi: 10.1002/eat.22501.

94. Kask J, Ramklint M, Kolia N, et al. Anorexia nervosa in males: excess mortality and psychiatric co-morbidity in 609 Swedish in-patients. Psychological Medicine 2017; 47 (8): 1489-99

95. Pettersen G, Wallin K, Björk T. How do males recover from eating disorders? An interview study. BMJ Open 2016; 6: 010760. doi:10.1136/bmjopen-2015-010760.

96. Striegel-Moore RH, Leslie D, Petrill SA, et al. One-year use and cost of inpatient and outpatient services among female and male patients with an eating disorder: evidence from a national database of health insurance claims. Int J Eat Disord 2000; 27: 381-9.

Conflict of interest statement: the Authors declare no potential conflits of interest or any financial or personal relationships with other people or organizations that could inappropriately bias conduct and findings of this study.